Nam Su Lee
Soonchunhyang University
31 Papers
138 Citations
Nam Su Lee is an academic researcher from Soonchunhyang University. The author has contributed to research in topics: Chemotherapy & Combination chemotherapy. The author has an hindex of 12, co-authored 31 publications. Previous affiliations of Nam Su Lee include Seoul National University & Soonchunhyang University Hospital.
Chat about Author
Papers
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Yoon-Koo Kang,Jeong Hwan Yook,Young-Kyu Park,Jong Seok Lee,Young-Woo Kim,Jin Young Kim,Min-Hee Ryu,Sun Young Rha,Ik Joo Chung,Inho Kim,Sang Cheul Oh,Young Soo Park,Taeil Son,Mi Ran Jung,Mi Hwa Heo,Hark Kyun Kim,Cho-Hyun Park,Chang Hak Yoo,Jin-Hyuk Choi,Dae Young Zang,You Jin Jang,Ji Young Sul,Jong Gwang Kim,Beom Su Kim,Seung Hoon Beom,Sang-Hee Cho,Seung Wan Ryu,Myeong-Cherl Kook,Baek-Yeol Ryoo,Hyunki Kim,Moon-Won Yoo,Nam Su Lee,Sang Ho Lee,Gyunji Kim,Yeonju Lee,Jee Hyun Lee,Sung Hoon Noh +36 more
TL;DR: Adjuvant chemotherapy after D2 gastrectomy is standard for resectable locally advanced gastric cancer (LAGC) in Asia as discussed by the authors, based on positive findings for perioperative chemotherapy in European ph...
Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases
Ji Yeon Kwon,Jina Yun,Han Jo Kim,Kyoung Ha Kim,Se Hyung Kim,Sang Cheol Lee,Hyun Jung Kim,Sang Byung Bae,Chan Kyu Kim,Nam Su Lee,Kyu Taek Lee,Seong Kyu Park,Jong-Ho Won,Dae Sik Hong,Hee Sook Park +14 more
TL;DR: Palliative chemotherapy could be considered in advanced gastric cancer patients with bone marrow metastases as a treatment option, and there were no chemotherapy-related deaths.
Pathophysiological role of hormones and cytokines in cancer cachexia.
Hyun Jung Kim,Han Jo Kim,Jina Yun,Kyoung Ha Kim,Se Hyung Kim,Sang-Cheol Lee,Sang Byung Bae,Chan Kyu Kim,Nam Su Lee,Kyu Taek Lee,Seong Kyu Park,Jong Ho Won,Hee Sook Park,Dae Sik Hong +13 more
TL;DR: A blunted adiponectin or ghrelin response to weight loss may contribute to cancer cachexia and IL-6 may be responsible for inducing and maintainingcancer cachexia.
Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
Jeeyun Lee,Tae-You Kim,Myung Ah Lee,Myung-Ju Ahn,Myung-Ju Ahn,Hoon-Kyo Kim,Ho Yeong Lim,Ho Yeong Lim,Nam Su Lee,Byung Joo Park,Jun Suk Kim +10 more
TL;DR: The combination chemotherapy with gemcitabine and cisplatin in this trial demonstrated moderate antitumor activity with favorable toxicity profile.
37
A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.
Hyun Jung Kim,Nam Su Lee,Sang-Cheol Lee,Sang Byung Bae,Chan Kyu Kim,Young Gook Cheon,Young Seok Kim,Jong Ho Moon,Young Deok Cho,Sang Heum Park,Kyu Taek Lee,Sung Kyu Park,Jong Ho Won,Hee Sook Park,Dae Sik Hong +14 more
TL;DR: Gemcitabine and dose adjusted oxaliplatin combination chemotherapy had moderate anti-tumor activity and was well tolerated as a first-line treatment for patients with inoperable BTC.
27